FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1149432009: Raltegravir potassium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4555722016 Raltegravir potassium en Synonym Active Entire term case insensitive SNOMED CT core module
4555723014 Raltegravir potassium (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Raltegravir potassium Is a Substance with integrase strand transfer inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Raltegravir potassium Is a Pyrrolidine true Inferred relationship Existential restriction modifier
Raltegravir potassium Has disposition Integrase strand transfer inhibitor true Inferred relationship Existential restriction modifier
Raltegravir potassium Is modification of Raltegravir true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely raltegravir (as raltegravir potassium) 400 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Raltegravir potassium Inferred relationship Existential restriction modifier 1
Product containing precisely raltegravir (as raltegravir potassium) 600 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Raltegravir potassium Inferred relationship Existential restriction modifier 1
Product containing precisely raltegravir (as raltegravir potassium) 100 milligram/1 each conventional release chewable tablet (clinical drug) Has precise active ingredient True Raltegravir potassium Inferred relationship Existential restriction modifier 1
Product containing precisely raltegravir (as raltegravir potassium) 25 milligram/1 each conventional release chewable tablet (clinical drug) Has precise active ingredient True Raltegravir potassium Inferred relationship Existential restriction modifier 1
Product containing precisely raltegravir (as raltegravir potassium) 100 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Has precise active ingredient True Raltegravir potassium Inferred relationship Existential restriction modifier 1

This concept is not in any reference sets

Back to Start